1. Canada needs a national COVID-19 inquiry now.
- Author
-
Fisman D, Horton J, Oliver M, Ungrin M, Vipond J, Wright JM, and Zoutman D
- Subjects
- Humans, Canada epidemiology, Public Health methods, SARS-CoV-2, Pandemics prevention & control, Health Policy, COVID-19 epidemiology, COVID-19 prevention & control
- Abstract
Background: We are now in the fifth year of an ongoing pandemic, and Canada continues to experience significant surges of COVID-19 infections. In addition to the acute impacts of deaths and hospitalizations, there is growing awareness of an accumulation of organ damage and disability which is building a "health debt" that will affect Canadians for decades to come. Calls in 2023 for an inquiry into the handling of the COVID-19 pandemic went unheeded, despite relevant precedent. Canada urgently needs a comprehensive review of its successes and failures to chart a better response in the near- and long-term., Main Body: While Canada fared better than many comparators in the early years of the COVID-19 pandemic, it is clearly still in a public health crisis. Infections are not only affecting Canadians' daily lives but also eroding healthcare capacity. Post-COVID condition is having accumulating and profound individual, social, and economic consequences. An inquiry is needed to understand the current evidence underlying policy choices, identify a better course of action on various fronts, and build resilience. More must be done to reduce transmission, including a serious public education campaign to better inform Canadians about COVID and effective mitigations, especially the benefits of respirator masks. We need a national standard for indoor air quality to make indoor public spaces safer, particularly schools. Data collection must be more robust, especially to understand and mitigate the disproportionate impacts on under-served communities and high-risk populations. General confidence in public health must be rebuilt, with a focus on communication and transparency. In particular, the wide variation in provincial policies has sown mistrust: evidence-based policy should be consistent. Finally, Canada's early success in vaccination has collapsed, and this development needs a careful post-mortem., Conclusions: A complete investigation of Canada's response to the pandemic is not yet possible because that response is still ongoing and, while we have learned much, there remain areas of dispute and uncertainty. However, an inquiry is needed to conduct a rapid assessment of the current evidence and policies and provide recommendations on how to improve in 2025 and beyond as well as guidance for future pandemics., Competing Interests: Declarations Ethics approval and consent to participate N/A. Consent for publication N/A. Competing interests Dr. David Fisman has served on advisory boards related to influenza and SARS-CoV-2 vaccines for Seqirus, Pfizer, Astrazeneca and Sanofi-Pasteur Vaccines, and has served as a legal expert on issues related to COVID-19 epidemiology for the Elementary Teachers Federation of Ontario and the Registered Nurses Association of Ontario. He is a member of the Canadian COVID Society. Dr. Jillian Horton has received speaking fees from AstraZeneca for delivering talks related to healthcare worker burnout. Dr. Mark Ungrin is the co-chair of the Legal Committee of the non-profit Canadian Covid Society. He receives no remuneration for this work. Dr. Joe Vipond is the co-chair of the non-profit Canadian Covid Society. He receives no remuneration for this work. Dr. Julia M. Wright served on the Royal Society of Canada’s Task Force on COVID-19 and now serves on the Board for the Canadian Lung Association. She receives no remuneration for this work. Dr. Dick Zoutman has served as an expert in legal proceedings and class actions concerning COVID-19. He is also a board member of the Canadian Covid Society for which he receives no renumeration. No other author has competing interestss COI to declare., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF